FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a prevention method of tick-borne encephalitis. Prevention method of tick-borne encephalitis by introducing an antiviral drug into the body is characterized in that after removing a tick to the place of suction, the application of a transdermal patch is made for introduction of a medicinal composition of human immunoglobulin against tick-borne encephalitis with tizol: immunoglobulin with an antibody titer to tick-borne encephalitis virus 1:320 1 ml, tizol to 5.0 g on dry skin in even thin layer at a rate of 0.2–0.5 g per 1 dm2 from 1 to 3 times a day.
EFFECT: above described prevention method of tick-borne encephalitis effectively reduces loads on patient’s immune system, simplifies procedures of introduction and eliminates infection of patient’s body by non-infasive use of drug.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF POST-EXPOSURE PREVENTION OF TICK-BORNE ENCEPHALITIS | 2017 |
|
RU2682677C2 |
METHOD OF TREATING FOCAL FORM OF MIXED ENCEPHALITIS-BORRELIOSIS INFECTION IN ACUTE PERIOD | 2015 |
|
RU2602740C1 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
AGENT "IODANTIPIRIN" FOR PROPHYLAXIS AND TREATMENT OF PATIENTS WITH TICK-BORNE ENCEPHALITIS | 1997 |
|
RU2141826C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2812292C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2809094C1 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2798102C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING TICK-BORNE ENCEPHALITIS | 2012 |
|
RU2472504C1 |
mRNA-BASED IMMUNOBIOLOGICAL AGENT FOR PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS | 2024 |
|
RU2823754C1 |
METHOD FOR PROPHYLAXIS OF TICK-BORNE ENCEPHALITIS IN CHILDREN | 2005 |
|
RU2281784C1 |
Authors
Dates
2019-03-11—Published
2018-10-09—Filed